§ Honest Comparison · Updated May 2026

PeptideApprove vs Easy Pay Direct

Both processors will onboard compliant peptide merchants. They differ on pricing transparency, reserve schedule, and what happens when your primary acquirer tightens risk appetite. Here's the honest side-by-side.

§ Verdict

Pick PeptideApprove if you want pricing confirmed in writing after underwriting, faster sponsor-bank review, and purpose-built KYB for peptide merchants. Pick Easy Pay Direct if you want the longer-established brand and don't mind quote-only pricing or a longer quote-and-compliance cycle.

Feature-by-feature

Side-by-side comparison.

Feature
PeptideApprove
Easy Pay Direct
Industry rate range pricing confirmed after underwriting 5–15%
Serves RUO + Healthcare ✓ Both tracks — RUO label-compliance path or LegitScript-certified pharmacy path Healthcare-licensed (LegitScript) only
Pricing model Confirmed after underwriting Quote-only, case-by-case
Reserve schedule Confirmed in the merchant agreement. 10–15% / 180 days
LegitScript for compliant RUO retailers ✓ Not required — Required, not bundled
Onboards MATCH-listed merchants Yes, with documented cause + LegitScript No — declines MATCH
Onboarding (compliant merchant) 48-hour underwriting response 4–6 weeks
Application fee $0 Varies
Early termination fee $0 Contract-dependent
Won't onboard guarantee If we can't lower your TCO, we won't onboard you —
Statement audit ✓ Yes — itemized, 24-hour turnaround — Not offered
Contact channel Web application + email Web application + phone
Established 2026 2014

The honest assessment

Where each one actually wins.

PeptideApprove wins on:

  • Pricing transparency. Pricing is confirmed in the merchant agreement after underwriting. Easy Pay Direct quotes case-by-case, which is conventional in high-risk but leaves room for interpretation.
  • Reserve schedule. Our reserve is released on a documented, published schedule. Easy Pay Direct's reserve is closer to the industry default of 10–15% held 180 days, which strangles working capital.
  • Backup acquirer. PeptideApprove focuses on faster sponsor-bank review, pricing confirmed in writing after underwriting, and payout flexibility. Easy Pay Direct is a longer-established brand, but its pricing and approval path can be less direct.
  • LegitScript. Not required for compliant research-use-only retailers. Clinical, pharmacy, and telehealth models are reviewed on a separate path. Easy Pay Direct's LegitScript requirement depends on the business model.
  • Onboarding speed. 48-hour underwriting response for eligible merchants with complete information, versus a 4–6 week quote-and-compliance cycle.

Easy Pay Direct wins on:

  • Brand longevity. Easy Pay Direct has been in the high-risk processing space since 2014. PeptideApprove launched in 2026. If brand age is your tiebreaker, EPD has more years on the books.
  • Phone-first service. EPD takes inbound sales calls. PeptideApprove is web-app + email until you've seen your quote — by design. If you prefer to talk to a sales rep before seeing a rate, EPD is the warmer experience.
  • Cross-category exposure. EPD processes for nutraceuticals, supplements, CBD, and several other high-risk categories — not just peptides. If your portfolio spans categories, that breadth matters. PeptideApprove is peptide-only by design.

Decision guide

Which one should you actually pick?

If you've already been terminated by Stripe or Shopify

Both will onboard you. PeptideApprove will quote you in one business day; EPD in 4–6 weeks. If cash flow matters, the difference is material.

If you're on the MATCH list

PeptideApprove. EPD declines MATCH applications. We can onboard with documented cause + a LegitScript certification path.

If you process across multiple high-risk categories

EPD. We're peptide-only. If you sell peptides AND supplements AND something else, EPD's cross-category exposure is the better fit.

If working capital efficiency matters

PeptideApprove. Our 90-day published reserve releases capital ~2× faster than the 180-day industry-default that EPD typically runs.

If you've never had a processor terminate you and you don't anticipate one will

Either works. But the question becomes whether you want a backup acquirer warm and waiting (PeptideApprove) or a single-MID setup (EPD). Most peptide founders who have been processing for 24+ months have been surprised at least once.

Send us your current statement. We'll show you what you'd save.

Side-by-side analysis in your inbox within 24 hours. No phone calls. No application fee. If we can't lower your total cost of ownership in year one, we won't onboard you.

Apply now → Apply now